Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Completed · Phase 3

Conditions studied: Pulmonary Disease, Chronic Obstructive

In brief

The purpose of this study is to see if fluticasone 500mcg/salmeterol 50mcg can improve the survival of subjects with COPD and also assess the long term safety profile of this drug.

Key facts

Study ID

NCT00268216

Run by

GlaxoSmithKline

People needed

6228

Starts

2000-09-01

Expected to finish

2005-11-01

Last updated by the study team

2017-01-20

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with COPD and FEV1 <60% of predicted normal and baseline (pre-bronchodilator) FEV1/FVC ratio <70%.
• Current or ex-smokers with a smoking history of at least 10 pack-years.

You may not qualify if…

• Diagnosis of other respiratory disorders (including asthma).
• Requirement for long term oxygen therapy.

Where it is running

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Jasper, Alabama, United States
• GSK Investigational Site — Mobile, Alabama, United States
• GSK Investigational Site — Ozark, Alabama, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Scottsdale, Arizona, United States
• GSK Investigational Site — Berkeley, California, United States
• GSK Investigational Site — Burbank, California, United States
• GSK Investigational Site — Encinitas, California, United States
• GSK Investigational Site — Fresno, California, United States
• GSK Investigational Site — Fullerton, California, United States
• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Rancho Mirage, California, United States
• GSK Investigational Site — Riverside, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Francisco, California, United States
• GSK Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.